H.B. Fuller (NYSE:FUL) Receives $84.20 Consensus Target Price from Analysts

H.B. Fuller (NYSE:FUL) has been given an average rating of “Reduce” by the four brokerages that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and three have given a hold rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $76.50.

FUL has been the topic of several recent research reports. Citigroup cut their target price on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Vertical Research downgraded H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. decreased their target price on H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a research report on Friday.

H.B. Fuller Stock Performance

Shares of FUL stock opened at $62.14 on Friday. The business has a 50 day simple moving average of $70.82 and a 200 day simple moving average of $76.79. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.89 and a quick ratio of 1.16. The firm has a market capitalization of $3.39 billion, a price-to-earnings ratio of 19.18, a price-to-earnings-growth ratio of 1.50 and a beta of 1.43. H.B. Fuller has a 12-month low of $60.96 and a 12-month high of $87.67.

H.B. Fuller (NYSE:FUL) last released its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.00 by ($0.08). The company had revenue of $923.00 million for the quarter, compared to the consensus estimate of $916.84 million. H.B. Fuller had a return on equity of 13.39% and a net margin of 5.15%. The business’s revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the business earned $1.32 earnings per share. On average, equities research analysts anticipate that H.B. Fuller will post 3.84 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wesbanco Bank Inc. lifted its stake in H.B. Fuller by 41.2% during the fourth quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after purchasing an additional 4,000 shares during the period. S&CO Inc. lifted its stake in H.B. Fuller by 0.3% during the third quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after purchasing an additional 920 shares during the period. Marshall Wace LLP lifted its stake in H.B. Fuller by 9.9% during the second quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock worth $22,319,000 after purchasing an additional 26,239 shares during the period. Lord Abbett & CO. LLC lifted its stake in H.B. Fuller by 79.8% during the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after purchasing an additional 324,056 shares during the period. Finally, Geode Capital Management LLC lifted its stake in H.B. Fuller by 1.5% during the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after purchasing an additional 18,734 shares during the period. Institutional investors own 95.93% of the company’s stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.